Canine CD34: Cloning of the cDNA and evaluation of an antiserum to recombinant protein

Blood

Volumn 88, Issue 6, 1996, Pages 1992-2003

  McSweeney, Peter A ^a   Rouleau, Katherine A ^b   Storb, Rainer ^b   Bolles, Laura ^b   Wallace, Philip M ^b   Beauchamp, Mary ^b   Krizanac Bengez, Ljiljana ^b   Moore, Peter ^b   Sale, George ^b   Sandmaier, Brenda ^b   De Revel, Thierry ^b   Appelbaum, Frederick R ^b   Nash, Richard A ^b  

^a USA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTISERUM; CD34 ANTIGEN; COMPLEMENTARY DNA; RECOMBINANT PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; DOG; GENE EXPRESSION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; LEUKEMIA CELL; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION; TISSUE SPECIFICITY;

EID: 9544237125     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.6.1992.bloodjournal8861992     Document Type: Article

References (46)

1. Civin CI, Strauss LC, Brovall C, Fackler MJ, Schwartz JF, Shaper JH: Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol 133:157, 1984
2. Katz FE, Tindle R, Sutherland R, Greaves MF: Identification of a membrane glycoprotein associated with haemopoietic progenitor cells. Leuk Res 9:191, 1985
3. Andrews RG, Singer JW, Bernstein ID: Monoclonal antibody 12.8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors. Blood 67:842, 1986
4. Fina L, Molgaard HV, Robertson D, Bradley NJ, Monaghan P, Delia D, Sutherland DR, Baker MA, Greaves MF: Expression of the CD34 gene in vascular endothelial cells. Blood 75:2417, 1990
5. Baumhueter S, Dybdal N, Kyle C, Lasky LA: Global vascular expression of murine CD34, a sialomucin-like endothelial ligand for L-selectin. Blood 84:2554, 1994
6. Young PE, Baumhueter S, Lasky LA: The sialomucin CD34 is expressed on hematopoietic cells and blood vessels during murine development. Blood 85:96, 1995
7. Strauss LC, Rowley SD, LaRussa VF, Sharkis SJ, Stuart RK, Civin CI: Antigenic analysis of hematopoiesis. V. Characterization of My-10 antigen expression by normal lymphohematopoietic progenitor cells. Exp Hematol 14:878, 1986
8. Simmons DL, Satterthwaite AB, Tenen DG, Seed B: Molecular cloning of a cDNA encoding CD34, a sialomucin of human hematopoietic stem cells. J Immunol 148:267, 1992
9. Satterthwaite AB, Burn TC, Le Beau MM, Tenen DG: Structure of the gene encoding CD34, a human hematopoietic stem cell antigen. Genomics 12:788, 1992
10. Brown J, Greaves MF, Molgaard HV: The gene encoding the stem cell antigen, CD34, is conserved in mouse and expressed in haemopoietic progenitor cell lines, brain, and embryonic fibroblasts. Int Immunol 3:175, 1991
11. Baumheter S, Singer MS, Henzel W, Hemmerich S, Renz M, Rosen SD, Lasky LA: Binding of L-selectin to the vascular sialomucin CD34. Science 262:436, 1993
12. Lu L, Walker D, Broxmeyer HE, Hoffman R, Hu W, Walker E: Characterization of adult human marrow hematopoietic progenitors highly enriched by two-color cell sorting with My10 and major histocompatibility class II monoclonal antibodies. J Immunol 139:1823, 1987
13. Krause DS, Takahiko I, Fackler MJ, Smith OM, Collector MI, Sharkis SJ, May WS: Characterization of murine CD34, a marker for hematopoietic progenitor and stem cells. Blood 84:691, 1994
14. + marrow cells engraft lethally irradiated baboons. J Clin Invest 81:951, 1988
15. + marrow cells in patients with breast cancer or neuroblastoma. Blood 77:1717, 1991
16. Shpall EJ, Jones RB, Bearman SI, Franklin WA, Archer PG, Curiel T, Bitter M, Claman HN, Stemmer SM, Purdy M, Myers SE, Hami L, Taffs S, Heimfeld S, Hallogan J, Berenson RJ: Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol 12:28, 1994
17. + peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood 86:390, 1995
18. Storb R, Thomas ED: Graft-versus-host disease in dog and man: The Seattle Experience, in Möller G (ed): Immunological Reviews. No. 88. Copenhagen, Denmark, Munksgaard, 1985, p 215
19. Kawakami T, Cain G, Taylor N: Establishment and partial characterization of a radiation-induced canine monocytic leukemic cell line (RK9ML-1). Leuk Res 13:709, 1989
20. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
21. Feinberg AP, Vogelstein B: A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6, 1983
22. Huss R, Hong DS, McSweeney PA, Hoy CA, Deeg HJ.: Differentiation of canine bone marrow cells with hemopoietic characteristics from an adherent stromal cell precursor. Proc Natl Acad Sci USA 92:748, 1995
23. Marchuk D, Drumm M, Saulino A, Collins FS: Construction of T-vectors, a rapid and general system for direct cloning of unmodified PCR products. Nucleic Acids Res 19:1154, 1991
24. Frohman MA, Dush MK, Martin GR: Rapid production of full-length cDNAs from rare transcripts: Amplification using a single gene-specific oligonucleotide primer. Proc Natl Acad Sci USA 85:8998, 1988
25. Short JM, Fernandez JM, Sorge JA, Huse WD: λ ZAP: A bacteriophage λ expression vector with in vivo excision properties. Nucleic Acids Res 16:7583, 1988
26. Sanger F, Nicklen S, Coulson AR: DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463, 1977
27. Wallace PM, Johnson JS, Macmaster JF, Kennedy KA, Gladstone P, Linsley PS: CTLA4Ig treatment ameliorates the lethality of murine graft-versus-host disease across major histocompatibility complex barriers. Transplantation 58:602, 1994
28. Linsley PS, Wallace PM, Johnson J, Gibson MG, Greene JL, Ledbetter JA, Singh C, Tepper MA: Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 257:792, 1992
29. Schuening F, Storb R, Goehle S, Meyer J, Graham TC, Deeg HJ, Appelbaum FR, Sale GE, Graf L, Loughran TP, Jr: Facilitation of engraftment of DLA-nonidentical marrow by treatment of recipients with monoclonal antibody directed against marrow cells surviving radiation. Transplantation 44:607, 1987
30. Denkers E, Badger CC, Ledbetter JA, Bernstein ID: Influence of antibody isotype on passive serotherapy of lymphoma. J Immunol 135:2183, 1985
31. Moore PF, Rossitto PV, Danilenko DM, Wielenga JJ, Raff RF, Severns E: Monoclonal antibodies specific for canine CD4 and CD8 define functional T-lymphocyte subsets and high density expression of CD4 by canine neutrophils. Tissue Antigens 40:75, 1992
32. Sandmaier BM, Schuening FG, Bianco JA, Rosenman SJ, Bernstein I, Goehle S, Storb R, Appelbaum FR: Biochemical characterization of a unique canine myeloid antigen. Leukemia 5:125, 1991
33. Rossbach H-C, Krizanac-Bengez L, Santos EB, Gooley TA, Sandmaier BM: An antibody to CD44 enhances hematopoiesis in long-term marrow cultures. Exp Hematol 24:221, 1996
34. Burn TC, Satterthwaite AB, Tenen DG: The human CD34 hematopoietic stem cell antigen promoter and a 3′ enhancer direct hematopoietic expression in tissue culture. Blood 80:3051, 1992
35. Wilusz J, Pettine SM, Shenk T: Functional analysis of point mutations in the AAUAAA motif of the SV40 late polyadenylation signal. Nucleic Acids Res 17:3899, 1989
36. Shaw G, Kamen R: A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46:659, 1986
37. Woodget JR, Gould KL, Hunter T: Substrate specificity of protein kinase C. Use of synthetic peptides corresponding to physiological sites as probes for substrate recognition requirements. Eur J Biochem 161:177, 1986
38. Patchinsky T, Hunter T, Esch FS, Cooper JA, Sefton BM: Analysis of the amino acids surrounding sites of tyrosine phosphorylation. Proc Natl Acad Sci USA 79:973, 1982
39. Devereux J, Haeberli P, Smithies O: A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res 12:387, 1984
40. Kozak M: Leader length and secondary structure modulate mRNA function under conditions of stress. Mol Cell Biol 8:2737, 1988
41. Sutherland DR, Watt SM, Dowden G, Karhi K, Baker MA, Greaves MF, Smart JE: Structural and partial amino acid sequence analysis of the human hematopoietic progenitor cell antigen CD34. Leukemia 2:793, 1988
42. Nakamura Y, Komano H, Nakauchi H: Two alternative forms of cDNA encoding CD34. Exp Hematol 21:236, 1993
43. Suda J, Sudo T, Ito M, Ohno N, Yamaguchi Y, Suda T: Two types of murine CD34 mRNA generated by alternative splicing. Blood 79:2288, 1992
44. Fackler MJ, Krause DS, Smith OM, Civin CI, May WS: Full-length but not truncated CD34 inhibits hematopoietic cell differentiation of M1 cells. Blood 85:3040, 1995
45. Krause DS, Fackler MJ, Civin CI, May WS: CD34: Structure, biology, and clinical utility. Blood 87:1, 1996
46. Uribe L, Henthorn PS, Grimaldi JC, Somberg R, Hartnett BJ, Felsburg PJ, Weinberg K: Cloning and expression of the canine CD38 gene. Blood 86:115a, 1995 (abstr, suppl 1)